Marshall Wace, LLP Horizon Therapeutics Public LTD CO Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $5.19 Million - $6.07 Million	52,484 Added 8.44%	674,698 $78.1 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $21.4 Million - $24.9 Million	221,893 Added 55.43%	622,214 $64 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $7.19 Million - $7.6 Million	-66,970 Reduced 14.33%	400,321 $43.7 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $127 Million - $232 Million	-2,039,038 Reduced 81.36%	467,291 $53.2 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $138 Million - $199 Million	2,347,834 Added 1481.33%	2,506,329 $155 Million

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $39.7 Million - $58.1 Million	-499,611 Reduced 75.92%	158,495 $12.6 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $86.3 Million - $110 Million	-998,573 Reduced 60.28%	658,106 $69.2 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $159 Million - $194 Million	1,614,010 Added 3782.63%	1,656,679 $179 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $3.92 Million - $4.71 Million	42,669 New	42,669 $4.67 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $267,085 - $297,064	-3,097 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $5.21 Million - $6.92 Million	-72,522 Reduced 95.9%	3,097 $285,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $4.4 Million - $5.54 Million	65,684 Added 661.14%	75,619 $5.53 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $5.76 Million - $8.34 Million	-104,307 Reduced 91.3%	9,935 $772,000
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $3.45 Million - $6.51 Million	114,242 New	114,242 $6.35 Million
Q2 2019 Aug 14, 2019	SELL	$22.81 - $28.48 $932,814 - $1.16 Million	-40,895 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$19.49 - $29.01 $797,043 - $1.19 Million	40,895 New	40,895 $1.08 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account